Putnam Biorevolution Ownership
| SYNB Etf | USD 30.52 0.23 0.76% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Putnam |
Putnam Etf Ownership Analysis
Putnam Biorevolution is is formed as Regulated Investment Company in the United States. ETF is managed and operated by State Street Bank and Trust Company. The fund has 35 constituents across multiple sectors and instustries. The fund charges 0.7 percent management fee with a total expences of 0.7 percent of total asset. The fund maintains 95.73% of assets in stocks. The fund invests mainly in common stocks of companies worldwide of any size with a focus on biology revolution companies. Putnam Biorevolution is traded on NYSEARCA Exchange in the United States.It is possible that Putnam Biorevolution ETF etf was renamed or delisted. To find out more about Putnam Biorevolution ETF contact the company at NA.Sector Exposure (%)
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Putnam Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Putnam Biorevolution , and the less return is expected.
Currency Exposure (%)
Investment Allocations (%)
Top Etf Constituents
| VRTX | Vertex Pharmaceuticals | Stock | |
| CTVA | Corteva | Stock | |
| AVTR | Avantor | Stock | |
| NGVT | Ingevity Corp | Stock | |
| LEGN | Legend Biotech Corp | Stock | |
| ZTS | Zoetis Inc | Stock | |
| MEDP | Medpace Holdings | Stock | |
| BMRN | Biomarin Pharmaceutical | Stock | |
| ALNY | Alnylam Pharmaceuticals | Stock | |
| DD | Dupont De Nemours | Stock | |
| TWST | Twist Bioscience Corp | Stock | |
| SY1 | Symrise AG | Stock | |
| DHR | Danaher | Stock | |
| ARGX | argenx NV ADR | Stock | |
| GOOGL | Alphabet Inc Class A | Stock | |
| CDNS | Cadence Design Systems | Stock | |
| LLY | Eli Lilly and | Stock | |
| NVZMY | Novozymes AS | Pink Sheet | |
| NVDA | NVIDIA | Stock | |
| BG | Bunge Limited | Stock | |
| CRSP | Crispr Therapeutics AG | Stock | |
| ASND | Ascendis Pharma AS | Stock | |
| ABBV | AbbVie Inc | Stock | |
| PPG | PPG Industries | Stock | |
| RCKT | Rocket Pharmaceuticals | Stock | |
| BIO | Bio Rad Laboratories | Stock | |
| ONON | On Holding | Stock | |
| TECH | Bio Techne Corp | Stock | |
| TMO | Thermo Fisher Scientific | Stock | |
| BRG | Borregaard ASA | Stock | |
| AZN | AstraZeneca PLC ADR | Stock | |
| DAR | Darling Ingredients | Stock | |
| EXAS | EXACT Sciences | Stock | |
| REGN | Regeneron Pharmaceuticals | Stock |
Putnam Biorevolution Outstanding Bonds
Putnam Biorevolution issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Putnam Biorevolution ETF uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Putnam bonds can be classified according to their maturity, which is the date when Putnam Biorevolution ETF has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Putnam Biorevolution ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Putnam Biorevolution's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Putnam Biorevolution Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Putnam Biorevolution Etf:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Putnam Biorevolution ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
The market value of Putnam Biorevolution ETF is measured differently than its book value, which is the value of Putnam that is recorded on the company's balance sheet. Investors also form their own opinion of Putnam Biorevolution's value that differs from its market value or its book value, called intrinsic value, which is Putnam Biorevolution's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Putnam Biorevolution's market value can be influenced by many factors that don't directly affect Putnam Biorevolution's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Putnam Biorevolution's value and its price as these two are different measures arrived at by different means. Investors typically determine if Putnam Biorevolution is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Putnam Biorevolution's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.